Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • Harvard Business Review (website)

Want to See the Future of Digital Health Tools? Look to Germany

By: Ariel Dora Stern, Henrik Matthies, Julia Hagen, Jan B. Brönneke and Jörg F. Debatin
  • Format:Electronic
ShareBar

Abstract

A new law will make it easier to introduce and determine the benefits of new tools. Perhaps its most important provisions are its formalization of “prescribable applications,” which include standard software, SaaS, and mobile as well as browser-based apps, and the creation of the Fast-Track Process, an accelerated regulatory path for companies to take their digital health applications to market. With at least 50 apps currently already in the Fast-Track process and hundreds expected over the coming years from manufacturers worldwide, evaluation studies will create a wealth of data on how digital tools for remote patient care work in practice, which other payers and health systems can learn from. They will also be valuable in convincing health care providers—for whom evidence is of paramount importance—of the value of digital tools, both generally and in particular use cases.

Keywords

Health Care and Treatment; Transformation; Online Technology; Technological Innovation; Germany

Citation

Stern, Ariel Dora, Henrik Matthies, Julia Hagen, Jan B. Brönneke, and Jörg F. Debatin. "Want to See the Future of Digital Health Tools? Look to Germany." Harvard Business Review (website) (December 2, 2020).
  • Register to Read

About The Author

Ariel D. Stern

Technology and Operations Management
→More Publications

More from the Authors

    • April 15, 2021
    • New England Journal of Medicine

    Remote Patient Monitoring—Overdue or Overused?

    By: Keizra Mecklai, Nicholas Smith, Ariel Dora Stern and Daniel B. Kramer
    • March, 2021
    • npj Digital Medicine

    Ushering in Safe, Effective, Secure, and Ethical Medicine in the Digital Era

    By: William J. Gordon, Andrea Coravos and Ariel Dora Stern
    • January–February 2021
    • American Journal of Therapeutics

    Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses

    By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
More from the Authors
  • Remote Patient Monitoring—Overdue or Overused? By: Keizra Mecklai, Nicholas Smith, Ariel Dora Stern and Daniel B. Kramer
  • Ushering in Safe, Effective, Secure, and Ethical Medicine in the Digital Era By: William J. Gordon, Andrea Coravos and Ariel Dora Stern
  • Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses By: Rachel E. Weitzman, Ariel Dora Stern and Daniel B. Kramer
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Digital Accessibility
Copyright © President & Fellows of Harvard College